Equine Salmonellosis: Serology and Cell Mediated Immunity in Naturally Infected Carriers after Hyperimmunization with an Autogenous Bacterin by Emerson, Carol Louise
EQUINE SALMONELLOSIS: SEROLOGY AND CELL MEDIATED 
,....l'•..'.> 
IMMUNITY IN NATURALLY INFECTED CARRIERS AFTER 
HYPERIMMUNIZATION WITH AN 
AUTOGENOUS BACTERIN 
By 
CAROL LOUISE EMERSON 
\\ 
Bachelor of Arts 
University of Hawaii 
Honolulu, Hawaii 
1974 
Bachelor of Science 
Washington State University 
, Pullman, Washington 
1978 
Doctor of Veterinary Medicine 
Washington State University 
Pullman, Washington 
1979 
Submitted to the Faculty of the Graduate College 
of the Oklahoma State University 
in partial fulfillment of the requirements 
for the Degree of 
MASTER OF SCIENCE 
December, 1985 

EQUINE SALMONELLOSIS: SEROLOGY AND CELL MEDIATED 
IMMUNITY IN NATURALLY INFECTED CARRIERS AFTER 
HYPERIMMUNIZATION WITH AN 
AUTOGENOUS BACTERIN 
Thesis Approved: 
Thesis Adviser 
Dean of the Graduate College 
ii 1236372 .~ 
ACKNOWLEDGMENTS 
The author would like to thank the members of her committee for 
their assistance in finishing this thesis. They are Dr. C. S. McCain, 
Dr. J. C. Wright, and Dr. J. T. Homer. Dr. McCain designed the project, 
Dr. Wright created a computer program for the lymphocyte stimulation 
data, and Dr. Homer answered many questions on immunology and helped 
edit the thesis. 
Thanks also to the Bovine Respiratory Disease Laboratory staff for 
help with experimental techniques. They are Chad Faulkner, Dr. Martha 
Gentry, Janet Durham, Judy Kreps, and Renee Simons. Thanks also to 
Dr. Anthony Confer for advice, supplies, use of his laboratory, and 
interpreting the histopathology. 
Since naturally infected horses were studied, this project depended 
on the cooperation of the College of Veterinary Medicine's Equine Clinic. 
Thanks to Dr. Frank Lockner, Dr. Steven Slusher, Dr. Charles McCallister, 
and John Black. 
Thanks also to Dr. Paul Barto for advice on bacterin production, 
Dr. Becky Morton for Salmonella sp. serotypes, Maria Payne for initial 
isolations fromclinic cases, Dr. Monica Howard for gross and 
histopathology and to Becky Jestes for technical assistance. 
The author would also like to acknowledge the support and encourage-
ment of her present department especially Dr. Gerald Van Hoosier and 
Dr. Lillian Price of the Division of Animal Medicine at the University 
of Washington. 
iii 
There are many others whose help made the completion of this 
thesis possible. Time and space do not permit the author to mention 
them; however, she would like them to know that all their help was 
greatly appreciated. 
iv 
TABLE OF CONTENTS 
Chapter 
I. INTRODUCTION. 
II. REVIEW OF THE LITERATURE •• 
The Genus Salmonella • • 
The Disease in Horses. • ••• 
The Carrier State •• 
> Antibiotic Therapy . • • 
Sources of Infection • • 
Public Health Aspects of Equine Salmonellosis. 
Serology .• 
Vaccines • • • • • 
Pathogenesis • • • • . • • 
Immune Response to Salmonella. 
Skin Testing in Horses 
Control. • • • • 
III. MATERIALS AND .METHODS • 
Experimental Animals • . 
Fecal Culture ••••• 
Antigen Preparation. • • • • 
Endotoxin Evaluation of Vaccines • 
Bacterial Agglutination Test • 
Skin Tests • • • • • • • • • • 
Pathology ••••••. 
Immunization Schedule. 
Blood Collection • • • • 
White Blood Cell Harvest 
Viability Measurement. • • ••• 
Standardization of the Cell Suspension • 
Leukocyte Migration Inhibition Test •• 
Lymphocyte Stimulation Test •• 
Data Analysis. 
IV. RESULTS • • 
V. DISCUSSION. 
VI. SUMMARY ••• 
v 
. . 
Page 
1 
3 
3 
4 
7 
8 
9 
9 
10 
12 
15 
17 
18 
19 
21 
21 
22 
23 
25 
25 
26 
26 
26 
27 
27 
29 
29 
29 
31 
32 
33 
58 
66 
Chapter 
A SELECTED BIBLIOGRAPHY. 
APPENDIX . 
vi 
Page 
68 
76 
LIST OF TABLES 
Table Page 
I. Skin Test Results for Horse A. 35 
II. Skin Test Results for Horse B. 36 
III. Skin Test Results for Horses C, D, and E . 37 
IV. Vaccination Schedule for Horse A . 39 
v. Vaccination Schedule for Horse B 40 
VI. Vaccination Schedule for Horses c, D, and E. 41 
VII. Salmonella Agglutinatipn Titers for Horse A. 42 
VIII. Salmonella Agglutination Titers for Horse B. . 44 
IX. Salmonella Agglutination Titers for Horses C, D, and E 45 
X. Salmonella Agglutination Titers for Control Horses F and 
G, Experiment I. . . . . . . . . . . . . . . . . 46 
XI. Salmonella Agglutination Titers for Control Horses F and 
G, Experiment II . . . . . . . . . . . . . . 47 
XII. Lymphocyte Blast Transformation Data, Serotype Agona 
Antigen #6--Experiment II. . . . . . . . . . . . . . 49 
XIII. Lymphocyte Blast Transformation Data, Serotype Agona 
Antigen #6--Experiment III . . . . . . 50 
XIV. Lymphocyte Stimulation Data for Horse B. 77 
XV. Lymphocyte Stimulation Data for Control Horse F. 78 
XVI. Lymphocyte Stimulation Data for Control Horse G. . 79 
XVII. Lymphocyte Stimulation Data for Horse c. 80 
XVIII. Lymphocyte Stimulation Data for Horse D. . . . . 81 
XIX. Lymphocyte Stimulation Data for Horse E. . . . . . 82 
vii 
Table 
XX. Lymphocyte Stimulation Data for Control Horse F. 
XXI. Lymphocyte Stimulation Data for Control Horse G .. 
viii 
Page 
83 
84 
LIST OF FIGURES 
Figure 
1. Experiment II: Comparison of Antigen Six Stimulation Indices 
(SI) of Test Horse B (Solid Line) with the Mean of Control 
Horses F and G (Dashes). Significant SI are Greater than 
Page 
Two • • • • . . . . . • • • • . • • . • . . . . . • • . • . • 51 
2. Experiment III: Comparison of Antigen Six Stimulation 
Indices (SI) of the Mean of Test Horses C, D, and E (Solid 
Line) with the Mean of Control Horses F and G (Dashes). 
Significant SI are Greater than Two . • 52 
3. Kidney. Horse B. Mild Glomerular Damage 
4. 
5. 
Spleen. Horse B. Secondary Follicle Development and 
Hemosiderin Deposition. . . • • . . • . . • • . 
Liver. Horse B. Necrotic Hepatocytes Surrounded by 
Polymorphonuclear Leucocytes •..•.•..•. 
6. Skin. Test Site. Horse B. Diffuse Inflammatory Infiltrate 
in the Dermis . 
ix 
53 
55 
56 
57 
CHAPTER I 
INTRODUCTION 
Bacteria in the genus Salmonella are a significant cause of 
morbidity and mortality in horses, especially foals which often die of 
an acute septicemia (1). Adults may also develop a septicemia but more 
commonly have an acute or chronic enteritis depending on which serotype 
causes the infection (2, 3). Recovered cases may become carriers and 
shed the bacteria in their feces for long periods during and after their 
convalescence. These horses contaminate the environment, acting as 
potential sources of infection for other horses and man, and increase 
the difficulty of controlling the disease (3, 4, 5). A means of 
identifying carriers would be very helpful. These horses could then 
be isolated to reduce the chance of further spread (3, 6). More 
knowledge about the carrier state of salmonellosis in horses, including 
tests to identify these animals, would be valuable to equine clinicians 
and owners. 
Diagnosis of bacterial enteric infections is accomplished by 
culturing feces. Since there are numerous bacteria in such samples, 
enrichment techniques that encourage the growth of salmonella while 
discouraging the growth of other bacteria are required (7). Fecal 
culturing is time consuming and expensive and may not detect some cases. 
A series of consecutive negative samples from an individual horse have 
been followed by isolation of the bacteria (8). Diagnosis of 
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salmonellosis in the inapparent carrier by fecal culture is difficult 
unless the horse is stressed and sheds the bacteria. Even then a fecal 
culture could be negative if there are low numbers of the organism 
present in the sample (8). 
Pathogenic salmonellae, Salmonella enteritidis typhimurium in 
particular, can survive and even multiply within cells of the reticula-
endothelial system (RES) (9, 10). Studies show that antibodies are able 
to reduce the severity of infection; but, cell mediated immunity (CMI) 
and activation of macrophages are the most significant responses for 
prevention or cure of salmonellosis (11, 12). 
Salmonella vaccines are still used in equine medicine, although not 
as frequently as in the past. Autogenous bacterins, prepared from 
Salmonella enteritidis serotype abortusequi appeared to have significantly 
reduced abortions caused by infection from this serotype (a host-specific 
salmonella that is no longer isolated in this country). Bacterins 
prepared from other serotypes have had varying degrees of success. The 
I 
best results have been obtained with bacterins to serotype typhimurium, 
used to vaccinate broodmares and improve foal survival on infected 
ranches (6, 13, 14, 15). 
Hyperimmunization, a series of injections of a bacterin given over 
a short period of time, has not been studied in salmonella carrier horses. 
The objective of this study was to evaluate the response of naturally 
infected carrier horses to hyperimmunization with autogenous bacterins. 
The horses used in this study were infected with Salmonella enteritidis 
serotypes, braenderup or agona. Immunological and clinical responses, 
fecal culture, and postmortem examination, were the basis for the 
evaluation. 
CHAPTER II 
REVIEW OF THE LITERATURE 
The Genus Salmonella 
Salmonella are members of the family Enterobacteriaceae, a very 
large and diverse group. This family consists of gram negative, medium-
sized rods, which are facultatively anaerobic, oxidase negative, 
non-sporeforming and fermentative bacteria. They are found in the 
intestines of man and animals, in the soil and on plants (16). The 
most recent classification scheme gives the genus three species. These 
are Salmonella cholerasuis, Salmonella typhi and Salmonella enteritidis 
which is further subdivided into serotypes. There are over 1700 serotypes 
of Salmonella enteritidis. Since the serotype is not a true subspecies, 
the nomenclature is variable, and one may see many ways of identifying 
the bacteria in the literature (17). 
The older classification system, the Kauffman-White Scheme, 
established relationships of salmonella called groups, which were based 
on shared common 0 antigens. The somatic or 0 antigen is a heat-stable 
polysaccharide associated with the body of the cell. Knowledge of the 
polysaccharide makeup of salmonella has demonstrated the sensitivity of 
the Kauffman-White classification scheme (18). The most striking 
difference between virulent and less virulent serotypes is related to the 
outer portion of the cell wall which is also responsible for 0 
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antigenicity (19). Most clinical isolates from man and animals were 
found in groups A through 0 (16). 
Besides the somatic antigen, there is also a flagellar or H antigen, 
which is heat labile and present in all motile salmonella. There are 
two genes that determine the structure of the flagellar filament subunit 
protein, flagellin. These genes are located on opposite sides of the 
genome and are expressed alternatively. Switches from one phase to the 
-3 -5 
other occur at frequencies of about 10 to 10 per cell generation (20). 
Phage typing and DNA hybridization have also been used to 
characterize salmonella isolates. Epidemiological studies using phage 
typing helped determine that birds were the most likely source of an 
outbreak since different phage types appear to be associated with certain 
hosts (10). Although unavailable in diagnostic laboratories at present, 
DNA hybridization may be the most accurate method of identifying the 
bacteria. This method has been especially useful when studying 
independent phenotypic factors not affected by plasmid-transferred 
genes (21, 22). 
The Disease in Horses 
The most common serotypes of salmonella associated with disease 
in horses are Salmonella enteritidis serotypes typhimurium, enteritidis, 
anatum, heidelberg and newport (2, 3). Other serotypes have been 
involved in outbreaks and in individual cases. Salmonella enteritidis 
serotype agona was found in a number of California horses but did not 
appear to be especially pathogenic (3, 23). Serotype typhimurium 
accounts for at least 60 percent of the isolations in most countries 
(2). 
Ingestion is the most common mode of infection for horses although the 
bacteria has been known to enter through mucous membranes (16). 
Salmonella are facultative intracellular parasites that localize in 
cells of the RES and associated lymph nodes (24, 25). Invasive strains 
may be taken up by macrophages and spread via the lymphatics (1, 3, 10, 
26). The pathogenesis of salmonellosis depends on the ability of the 
organism to: invade the gastrointestinal mucosa, cause diarrhea, and 
disseminate from the intestine and multiply within the RES (27). The 
most severe gastrointestinal lesions associated with equine 
salmonellosis are located in the distal ileum, proximal colon and 
cecum (28). At postmortem, the best tissues to collect for possible 
salmonella isolation are mesenteric lymph nodes, mucosa of the cecum 
and proximal large colon, distal ileum, the liver and the spleen (3). 
Clinically salmonellosis in horses can be divided into categories 
based on time of onset of clinical signs after introduction of the 
bacteria and the type of disease produced. These have been identified 
in naturally infected horses as well as in experimental infections 
(29, 30). Age of the host and pathogenicity of the serotype influence 
the signs. Onset may be peracute, acute, chronic, or the infection 
may be inapparent and the animal considered a carrier. 
Foals less than six months old frequently show the peracute form 
of the disease. The onset is very rapid and resembles a toxemia or 
septicemia with or without diarrhea. The mortality rate is very high 
with death occurring 24 to 72 hours after the foal first appears sick. 
Joint localization of the infection and arthritis can be sequelae if the 
animal recovers (1, 3). 
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The acute form of the disease occurs most frequently in adult horses 
(2, 3). They may be febrile, weak, anorectic and have liquid feces that 
may contain blood, mucus, or pieces of the intestinal mucosa. A severe 
diarrhea can persist in these animals for several weeks with concomitant 
weight loss and dehydration (2). In milder cases a horse may show only 
a loss of appetite followed by depression and fever without a severe 
diarrhea. Although not a consistent finding, neutropenia in the early 
stages of illness can be helpful in alerting the equine clinician that 
salmonellosis should be included in the differential diagnosis (3, 29, 
31, 32). Patients with the acute form of the disease may die, recover, 
or become chronic cases. 
Horses with chronic salmonellosis may have a persistent diarrhea 
even though their appetite and temperature are normal. Recovery may 
occur, but if diarrhea lasts more than five weeks the patient usually 
dies because of dehydration and weight loss. Chronic cases are quite 
refractory to therapy and have a grave prognosis (2). 
The clinical course of salmonellosis can be influenced by many 
factors including virulence of the serotype, number of organisms in the 
inoculum, portal of entry, immune competence of the host, stress, and 
time of year (10, 33). Examples of stresses are: anthelmintics, change 
in diet or a dietary deficiency, lack of food or water, strenous 
exercise, surgery, shipping, change of stables, antimicrobial therapy or 
concomitant disease (6, 21). When the host is stressed, the organism 
multiplies in the gut and is shed in the feces (34, 35). During the 
summer months more cases of salmonellosis are reported. This may be a 
result of stress due to management problems rather than weather. Animals 
may have inadequate shade, may not have enough water or may be kept in 
enclosures with insufficient ventilation (5, 10). 
The Carrier State 
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The carrier state is especially important in the epidemiology of 
salmonellosis in horses because carrier horses help maintain the 
infection on isolated farms (3, 6). In surveys of fecal shedders, the 
less pathogenic serotypes such as agona or anatum have been isolated more 
frequently. Serotype typhimurium is rarely cultured from asymptomatic 
carriers except during convalescence. The number of horses shedding the 
bacteria is related to the region of the country, the season, the 
population studied, the tissues sampled, and cultural technique used (3). 
Some horses are diagnosed as carriers after they die unexpectedly 
and characteristic postmortem lesions are found along with recovery of 
the organism (36). Death from salmonellosis often occurs in horses which 
are referred to veterinary hospitals for surgery. These horses are 
possibly inapparent carriers and they recover from the surgical procedure 
but develop acute salmonellosis due to the stress of surgery (3, 6, 21). 
Foals born to carrier dams, frequently die from salmonellosis 
because the mare sheds the organism after the stress of parturition. 
The offspring is exposed to the organism by suckling from a contaminated 
udder and from a tendency to be copraphagic (28, 34). A consistent loss 
of foals may be the only clue that a mare is a carrier; but such a 
pattern could be overlooked on a large ranch unless careful records 
are kept and thorough postmortem examinations are performed. 
A carrier can be identified by culturing the feces if the horse 
is shedding the bacteria consistently and in great enough numbers to 
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be isolated (3, 29, 36). Multiple samples from an individual increase the 
chance of isolating the bacteria (8). A compromise of between three and 
five consecutive fecal samples is most frequently used by equine clinicians 
(3, 8). Demonstration of the bacteria on a herd basis has been more 
reliable than individual animal culture (10). Some horses with chronic 
diarrhea were identified as carriers after rectal biopsies were taken 
(37, 38). 
Antibiotic Therapy 
Antimicrobial agents have not been recommended in the treatment of 
uncomplicated, non-typhoidal salmonellosis because of prolongation of 
fecal shedding of bacteria without apparent therapeutic effect. 
Correction of dehydration and electrolyte imbalances have produced a 
more significant clinical response than antibiotic therapy unless the 
signs are particularly severe or the animal is septicemic (1, 21, 39). 
The course of the disease has not been shortened with antibiotics and 
they are known to prolong the period of convalescent shedding (1, 15, 
39). 
Also, the presence of bacteria resistant to antibiotics is of 
great concern. The R factor, a plasmid common to the Enterobacteriaceae, 
is responsible for resistance to drugs such as tetracycline, kanamycin, 
chloramphenicol and streptomycin (40, 41, 42). Transferable anti-
microbial resistance mediated by R factors has been well documented 
for salmonella especially for serotype typhimurium (22). 
Besides providing no clinical improvement, prolonging the carrier 
state and potentially introducing multiple drug resistance, antibiotic 
therapy in horses with salmonellosis disrupts the normal gut flora. 
This normal flora competes with salmonella and other pathogens (43). 
Some mild cases of equine salmonellosis have progressed to acute 
fulminating septicemias following antibiotic therapy (especially with 
tetracyclines) (44). 
Sources of Infection 
Besides exposure to a carrier, there are many sources of infection 
for the horse. Vitamin supplements, water and hay grown on fields using 
contaminated water have been incriminated in outbreaks of salmonellosis 
(10, 21). Sporadic cases occur more often from direct contact with an 
infected animal or from contaminated soil while epidemics of 
salmonellosis are frequently traced to a contaminated food source (16). 
Salmonella may remain alive in the soil for long periods of time. 
Serotype typhimurium survived 120 days in pasture soil and 280 days in 
well fertilized gardens (26, 30). Other serotypes survived six weeks on 
vegetation at room temperature and for at least 28 months in dried, 
naturally infected bird droppings (45). The numbers of bacteria in 
contaminated soil generally decreased with time, but multiplication 
can occur if organic material and water are plentiful (46, 47). 
Public Health Aspects of Equine Salmonellosis 
Horses occupy a unique position in our culture and are no longer 
considered just working animals. The majority are companion animals 
and often have a very close association with their owners. Equine 
salmonellosis has important public health implications (5, 21). The 
prevalence of the carrier state in horses is unknown and the number of 
cases may be underestimated. Many mild cases are missed if culturing 
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is not performed and if recovery is prompt. Serotype agona has been 
isolated from horses and from people with gastrointestinal disease (3, 
48). Human cases of salmonellosis from contact with pleasure horses 
have been reported with the majority of cases occurring in veterinarians 
who had treated infected horses (39, 49, SO). Animals, including horses, 
are considered to be the greatest reservoir and source of infection 
for salmonella in man (22). 
Serology 
Serological techniques have been used to diagnose salmonellosis in 
man, cattle and horses and they have saved significant amounts of time 
in making a diagnosis when compared to fecal cultures. Serology has 
also been used extensively in the poultry industry to identify carriers 
of pullorum disease, Salmonella enteritidis bioserotype pullorum and 
fowl typhoid, Salmonella enteritidis bioserotype gallinarum (51, 52). 
Agglutination titers have been used in horses infected with 
Salmonella enteritidis serotype abortusequi. The presence of antibodies 
to H antigens were considered to be indicators of recent infections (28, 
53). Since this bacteria shares antigens with other members of the 
Enterobacteriaceae, false positives may occur; however, titers of 
infected animals are usually much higher than those of noninfected 
animals (54, 55, 56). A battery of 0 and H antigens of the most common 
serotypes of Salmonella enteritidi~ may help to determine if an organism 
isolated from a specimen represents a true infection or a contaminant. 
At least a fourfold rise in titer should be demonstrated during the 
course of infection (22). 
Indirect hemagglutination (IRA), a more sensitive test than the 
standard tube bacterial agglutination technique, was used to detect 
antibodies to Salmonella enteritidis serotype dublin in cattle. 
Infected herds exhibited significantly higher titers than non-infected 
herds. Herd evaluation was found to be more reliable than individual 
animal testing (57). Titers greater than 80 in an individual indicated 
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a potential infection. IRA has been useful in determining whether an 
immune response developed following infection. As with the agglutination 
test, a rise in titer was necessary to substantiate an active infection 
(22). 
An enzyme-linked immunosorbent assay (ELISA) test has been developed 
to test mice and rats in commercial laboratories and in research 
facilities for Salmonella enteritidis serotypes typhimurium, rubislaw, 
and enteritidis (58). Different degrees of cross reactivity between 
serotypes were found (59). Typhimurium was the' most cross reactive 
and enteritidis was more cross reactive than rubislaw. Once experi-
mentally infected animals seroconverted, the ELISA test was more sensitive 
for detecting infected animals than was fecal culture. False positive 
reactions due to cross reactions were found to be negligible. An 
ELISA test was evaluated during a human outbreak of salmonellosis in 
Sweden. Estimation of the increase in titer of antibodies against the 
0 antigen correctly identified 92 percent of the patients who were 
culturally positive for the organism (59). 
Immunofluorescence has been used to identify salmonella in various 
foodstuffs (60). However, the test was never very accurate due to 
marked cross reactivity. A new synthetic disaccharide hapten which 
represents an 0 antigen coupled to a protein carrier has been developed 
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(61). Antisera produced from this synthetic hapten has been highly 
specific when used to identify salmonella by indirect immunofluorescence 
(!FA). During a large human outbreak (3000 cases) of Salmonella 
enteritidis serotype enteritidis, IFA was used to screen fecal cultures 
on enriched media reducing culture time and markedly increasing the 
sensitivity of the isolation technique (61). 
With the development of more sensitive and specific tests and 
synthetic antigens, serology could be a significant aid in the diagnosis 
of salmonellosis especially for the carrier animal or when fecal cultures 
are negative (21). However, antibody evaluation is still an indirect 
test, requiring the host to respond before a presumptive diagnosis can 
be made (58). Even if the host responds, there is a delay after 
infection before antibodies are produced and reach detectable levels. 
Serologic techniques including ELISA and IFA, have been used to 
detect significant antibody titers in animals. There is a great need 
for such tests to aid in diagnosis of equine salmonellosis and to 
determine the prevalence of the disease. However, little has been done 
to evaluate these tests in horses. 
Vaccines 
The use of salmonella bacterins in horses began with the isolation 
and identification of serotype abortusequi (6, 14, 15, 53). These 
bacterins were used for prevention because immunity was brief and 
protection lasted for less than a year. Mares were vaccinated during 
the fourth and ninth months of gestation and then were boostered yearly 
in the fall (14). Since vaccination was so common and since this 
serotype is no longer isolated, bacterins have been credited with 
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eradication of abortusequi in this country (16, 21, 53). The most common 
bacterins used against salmonellosis in horses were heat-killed and 
were preferred because it was thought that somatic, or 0 antigen, was 
more accessible (14, 62). At present, a controversy concerning the 
efficacy of salmonella bacterins in horses exists and their use by equine 
clinicians has declined (6). There have been reports of successful 
vaccination programs for serotypes other than abortusequi (14, 15). 
Favorable results have been noted in mares who were vaccinated with 
a formalin-killed bacterin prepared fromaculture of the serotype 
typhimurium isolated on a breeding farm. Two doses of the bacterin were 
given at 90 and 60 days before foaling. Foal heat diarrheas were less 
severe and the serotype was not isolated from the feces of the mares (15). 
Vaccine efficacy in horses is difficult to evaluate in the 
literature. Many techniques were used to make the vaccines, only small 
numbers of animals were vaccinated, no controls were used and different 
' 
serotypes were compared. In much of the literature, the efficacy of 
the vaccine was based on the clinical impression of the attending 
veterinarian (14, 15, 63). Hyperimmunization has been evaluated in mice 
(64, 65). A series of six intraperitoneal injections of Salmonella 
typhi vaccine failed to protect BALB/c or C57BL mice from as few as 10 
virulent organisms of serotype typhimurium. Hyperimmunization has 
not been well studied in other animals including horses (66) . 
Live vaccines have been developed; however, the strain to be used 
for a vaccine must be stable, must not revert to a virulent form and 
must provide protection (67). Host-adapted serotypes have been 
inoculated into abnormal hosts in attempts to stimulate immunity 
without disease (12). Mice were injected intraperitoneally with 107 
organisms of bioserotype pullorum daily for eight consecutive days, 
combining hyperimmunization and the use of a live vaccine (64). The 
mice were challenged on day eight with an Ln50 of serotype enteritidis. 
Livers and spleens were cultured and daily blood counts were made on 
randomly selected test and control mice. In vaccinated animals, the 
challenge dose of serotype enteritidis was cleared rapidly from the 
blood but organisms increased in the liver and spleen until the fifth 
day post challenge. The numbers then declined in these tissues. 
Hyperimmunized mice were more resistant to the toxic effects of heat-
killed cells and purified lipopolysaccharide (65). 
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A great deal of recent research has been done on vaccines to protect 
cattle from serotype dublin (68, 69, 70, 71). Avirulent rough colony 
mutants have been used successfully as vaccines in calves and have been 
commercially available for years (72). An appreciation for the amount 
of work required to identify and test mutants as possible vaccine 
strains can be gained from one study. Fifty-five different ways to 
culture Salmonella enteritidis serotype dublin were evaluated, including 
growth at different temperatures, on various media, and for different 
lengths of time. Mice were initially used to evaluate the mutant 
strains for efficacy in the previously mentioned study. However, the 
vaccines which afforded the best protection for mice did not provide 
protection for calves in clinical trials. Testing was then repeated on 
calves. The best protection in calves was provided by entirely 
different strains than those that protected mice (67). 
There are reports of problems associated with the serotype dublin 
strain 51 commercially available vaccine. Some calves excreted the 
organism after vaccination and there were a few cases of postvaccination 
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anaphylaxis (68, 69, 70, 71). Vaccination of cows in order to passively 
immunize their calves against serotype dublin has also been studied. The 
results of these studies have not been consistent (72). 
RecornbinantDNA techniques have been used to produce live salmonella 
vaccines and will probably account for most of the future vaccines (73). 
Salmonella typhi, TY21a, a galactose epimerase mutant, has been tested 
as a live oral vaccine in children in India (74). Reactions to the 
vaccine occurred in less than one percent of the vaccinees and involved 
only a slight diarrhea or soft stool for 24 hours or less (12). 
A nonpathogenic mutant of serotype typhimurium (Me Aro-Strain) has 
been used in calves and mice. This strain requires the aromatic 
metabolites, para-aminobenzoate (to make enterochelin for iron uptake) 
and para-aminobenzoic acid (to make folate) which are not available in a 
mammalian host (69, 75). Mice were protected by the strain when 
challenged using virulent serotype typhimurium (69). Cross serotype 
protection has also been observed in cattle. Calves vaccinated with 
serotype dublin had significantly fewer deaths compared to controls 
after challenge with virulent serotype typhimurium. Similar results 
occurred when calves were vaccinated with serotype typhimurium and 
challenged with serotype dublin (69). 
Pathogenesis 
The enterocolitis syndrome caused by nontyphoidal serotypes 
generally does not last very long and frequently is self-limiting. 
After ingestion, the bacteria multiply in the small intestine and colon 
leading to inflammation of the lamina propria and villi (22). The 
response is primarily by neutrophils, while in cases of typhoid and 
paratyphoid fevers, the response is a mononuclear one. The immunity 
produced by nontyphoidal enterocolitis is short-lived and repeated 
infections due to the same serotype are common. In a susceptible host 
almost any virulent serotype can cause enteric fever, although large 
numbers may be required to produce disease (22). After ingestion, 
salmonella attach preferentially to villus tips, pass into the lamina 
propria, multiply, and are engulfed by phagocytes. 
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The sites of invasion initially show no evidence of cellular damage 
or inflammation, but neutrophils soon appear, marginate in submucosal 
vessels, and move into the villus. This suggests that mucosal damage 
is partially due to the response of the host (27). 
A number of animal models have been used to evaluate virulence of 
a serotype of salmonella. These include mouse intraperitoneal 
inoculation, rhesus monkey inoculation, the rabbit ileal loop test and 
guinea pig Ln50 evaluations. The rabbit ileal loop has been the best 
model for assessing the invasive and fluid-producing ability of serotype 
typhimurium. Using this model, it was found that virulence differences 
exist between different strains of a single serotype. For example, 
strains SR-2 and Thax-1 did not invade the mucosa while W118, TML, 
SL 1027, LT-7, and PG-41 did, even though the number of bacteria 
attached to the epithelial cells and within the mucosa were similar. 
If the bacteria were injected into the general circulation, strains 
W118 and TML were cultured more frequently from the liver and spleen 
while strain M206 was rapidly cleared by the RE. Some strains of 
serotype typhimurium induce fluid secretion. Strain M206 which produced 
minimal histological mucosal inflammation evoked fluid secretion 
comparable to the more pathogenic strains W118 and TML. Strains SL 1027, 
LT-7 and PG-41 can invade the mucosa and cause extensive inflammation 
without fluid secretion (27). 
Using the rabbit ileal loop model and strain TML of serotype 
typhimurium, histology of the infection was studied. The majority of 
the villi were blunted, swollen, hypercellular and were cuboidal to 
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low columnar in shape. The lamina propria was edematous and extensively 
infiltrated with neutrophils. The goblet cells contained no mucus. The 
crypts increased in depth and contained numerous mitotic figures. 
Mucosal blood vessels appeared normal and ulceration was not usually 
observed (9). 
A less virulent strain, SL 1027, produced fewer alterations in the 
mucosa with only 15 to 30 percent of the villis showing edema, blunted 
tips and infiltration with neutrophils. The organisms within phagocytes 
were morphologically intact despite exposure to digestive components 
within vacuoles. Virulent serotypes have the ability to survive and 
multiply within the vacuoles (9). 
Immune Response to Salmonella 
Although vaccines from killed organisms increase the resistance to 
salmonellosis, a more solid immunity develops from natural infection 
or vaccination with live bacteria (10). Specific antibodies increase 
phagocytosis by opsonization; however, a humoral response to serotype 
enteritidis in mice has been demonstrated to occur without any 
resistance to challenge infection (64, 65, 76, 77). The amount of 
protection that serum has been able to provide by passive immunization 
depended on the route of administration and time between immunization 
and challenge (78). 
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Since pathogenic salmonella can resist phagocytosis,effective 
resistance is primarily due to cell mediated immunity as for most 
facultative intracellular bacteria (65, 79). Effective vaccines must 
stimulate CMI to be effective but humoral immunity may or may not occur. 
In studies us.ing calves, a Salmonella enteritidis serotype dublin 
vaccine provided protection against challenge from a virulent strain 
without a marked antibody response. Agglutination titers were low and 
did not correlate with protection (68). 
Skin Testing in Horses 
Skin testing for diseases such as tuberculosis and glanders has 
been used in horses. The mallein test for glanders uses antigens 
prepared from media on which the bacteria has been grown. The antigen 
is injected intradermally or subcutaneously into the palpebrae. The 
test is read in 72 hours and swelling around the eyes indicates a 
positive response (80, 81). 
One study evaluated the tuberculin test in horses intended for 
slaughter and found no significant correlation between the intradermal 
test response, findings at postmortem, and isolation of pathogenic 
Mycobacteria (82). Reasons for the poor response to the tuberculin 
skin test were unknown. The response may have been due to the nature 
of the test or to other factors such as a low infection rate. Skin 
testing has not been performed as an aid in diagnosing cases of equine 
salmonellosis. 
The correlation between serum immunoglobulin levels, lymphocyte 
transformation studies and dermal responses in horses with chronic 
diarrhea was studied (83). No etiologies were given for the diarrheas. 
The results indicated that the serum concentration of immunoglobulin G 
(IgG) was greater in sick horses. However, lymphocytes showed a 
transient depression in their response to phytohemagglutinin A (PHA), 
in transformation studies and the intradermal skin tests using antigens 
from common liorse feeds were significantly less than in normal horses. 
The horse in this study appeared to be immunosuppressed (83). 
Skin testing with PHA has been used to identify horses with 
combined immunodeficiency and resultant inability to mount a cell 
mediated immune response (84, 85) . Fifty micrograms of PHA can 
be injected intradermally to evaluate the ability of the horse to 
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mount a cell-mediated immune response (83, 86, 87). After intradermal 
injection, there is a noticeable swelling within four hours that peaks 
between 24 and 72 hours. Histological examination of biopsies at the 
injection site shows primarily a mononuclear infiltrate although mast 
cells were also present in normal horses. The combined immunodeficient 
Arabian foals have a reaction that peaks at four hours and then steadily 
declines (84, 85). 
Control 
Since salmonella can survive for long periods in the soil, good 
animal management and husbandry techniques could help reduce exposure 
from environmental contaminants. Identification and isolation or 
euthanasia of carrier horses would also help reduce infection in 
susceptible horses and environmental contamination. Pasture rotation 
could reduce the incidence of salmonellosis on certain property (45, 46, 
47). Standing water should be drained. No other animals should be 
allowed to graze on infected pasture and forage crops should not be 
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grown on contaminated land. Carcasses or any source of organic material 
should be removed in order to reduce the potential for multiplication of 
the organism (10). Control and prevention of salmonellosis is extremely 
difficult because the bacteria is so hardy and widespread in nature 
(45). 
CHAPTER III 
MATERIALS AND METHODS 
Experimental Animals 
Three experiments were performed using five infected horses and two 
controls. Experiment I involved, horse A, a two year old, quarterhorse 
filly which was shedding Salmonella enteritidis serotype braenderup. 
Isolation of the bacteria was made by the microbiology laboratory at the 
veterinary school and was typed by the National Veterinary Services 
Laboratory at Ames, Iowa. 
A two year old, quarterhorse filly, horse B was used in experiment 
II. She was shedding serotype agona in her feces. Both horses were kept 
in isolation stalls which were approximately 14 square meters. 
The third experiment involved three privately owned yearling 
quarterhorses, two females, C and D, and a castrated male, E. They 
were from the same ranch as horse B and were also shedding serotype agona. 
After these horses were found to be shedding the bacteria, they were 
isolated from other horses and kept on grass pasture. An autogenous 
bacterin (Bio-Med Research Laboratories, Seattle, Washington) had been 
prepared for this farm from an isolate of serotype agona. Horses C, 
D and E had received a series of three vaccinations of this commercial 
preparation given at two week intervals six months before they were 
involved in this research. 
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Two horses, F and G, which were culturally negative for salmonella 
were used as controls in experiments II and III. Horse F was a five 
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year old Appaloosa stallion and horse G was a three year old quarterhorse 
gelding. 
Fecal Culture 
All media used were obtained from Difco Laboratories, Detroit, 
Michigan and reagent grade chemicals were used to prepare the phosphate 
buffered saline (PBS). 
Salmonella were isolated from feces using enrichment techniques. 
For horse A, 10 ml of PBS was added to 10 g of feces, macerated, then 
one loopful was used to streak a HacConkeys and brilliant green agar 
plate. One ml of the diluted feces was added to 10 ml of selenite broth 
and the remainder of the diluted feces was added to 100 ml of tetra-
thionate broth. Subcultures from the enrichment broths were made on 
brilliant green and Salmonella-Shigella agar. A different protocol was 
used for the other horses (90). One ml of sterile PBS was added to 30 g 
of feces in a sterile polypropylene tissue collection bag. This was 
placed in a second bag, then macerated for one minute using a Stomaker 
(Tekmar Co., Cincinnati, Ohio). A loopful was used to directly streak 
MacConkeys and brilliant green agar plates for isolation. One ml of the 
diluted feces was added to 10 ml of selenite broth and incubated at 
37 C, and the rest of the feces were added to 100 ml of tetrathionate 
broth and put in a tissue collection bag along with one to two mls of 
iodine to retard the growth of other enteric bacteria. The bag was 
placed in a container to give it support and incubated at 40 C. The 
enrichment broths were incubated for 24 hours then subcultured to 
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MacConkeys and brilliant green agar plates by streaking the plates. The 
enriched fecal samples were then reincubated for a second 24 hours and 
subcultured a second time. Plates were incubated for 24 hours, then 
observed. After biochemical and polyvalent 0 antiserum testing, a 
positive isolate was evaluated using an API-20 E (Analytical Products, 
Plainview, New York) and if identified as a salmonella, was sent to 
the National Veterinary Services Laboratory in Ames, Iowa for serotyping. 
Feces from horses A and B were cultured twice during the experiment 
and at postmortem. Feces were collected from horses C, D, and E three 
times: before, during and after the vaccination series in experiment III. 
Five consecutive fecals from the control horses were collected and 
cultured for salmonella. Both control horses were found to be negative 
before they were used in the experiment. 
Antigen Preparation 
In order to grow large numbers of the organisms, eight ounce 
prescription bottles were filled with a thin slant of brain 
heart infusion (BHI) agar. Serotypes were inoculated into three ml 
of BHI broth, vortexed and then 0.5 ml was used to inoculate each 
of six prescription bottles. Following an 18 hour incubation, bacteria 
were harvested from the bottles in three ml of PBS by periodic rocking 
for one hour. The bacteria-rich saline was transferred to sterile 
vaccine bottles and the bacteria were killed by adding 0.6 percent 
formalin-saline solution sufficient to make a McFarland tube three 
concentration (91, 92). Inactivation of the bacteria with formalin 
preserves the H antigens (93). 
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The formalin-killed vaccine prepared for horses C, D, and E was 
also heated in a waterbath at 60 C for one hour to ensure that the 
organism was killed. The antigen preparations were tested for sterility 
after two days of room temperature incubation by inoculating three tubes 
of fluid thioglycolate with 0.1, 0.5, or one ml of antigen. The tubes 
were incubated at 37 C and observed for growth at 24 and 48 hours. Some 
of the bacterial suspension of serotypes agona and braenderup was not 
diluted. Instead, it was killed with one ml of 40 percent formaldehyde 
solution and tested for sterility as previously described except that 
only 0.1 ml of the antigen was inoculated into fluid thioglycolate. 
Dilutions for skin testing were made from this concentrated antigen 
and used to evaluate the sensitivity of each animal to the antigen so 
that the best antigen dose would be used during vaccination. 
0 antigens were prepared using the following technique. Bacteria 
were grown and harvested as described for the H antigen. The bacterial 
suspensions were collected and placed in sterile 100 ml vaccine bottles 
with sufficient PBS to give a McFarland three turbidity. These bottles 
were placed in a water bath at 60 C for one hour then sterility was 
checked using the same method as described previously and the antigens 
were stored at 5 C (91, 92, 93). 
Ten antigen dilutions were prepared from heat-killed serotype agona 
and were used in the Macrophage Inhibition Factor (MIF) and Lymphocyte 
Stimulation (LST) tests. Serial, two-fold dilutions of the organism 
were made in RPMI-1640 (Gibco, Grand Isle, New York). Two ml aliquots 
of the antigens were then placed in screw-top, sterile plastic tubes 
and kept at 5 C until the morning of a test. 
The serotype agona isolated from horse B in experiment II was also 
used to prepare H and 0 antigens used in experiment III. Similar 
preparations were made from serotypes newport, typhimurium, heidelberg 
and anatum by the previously described techniques. Each of these 
serotypes represented a group classification according to Ewing's 
abbreviated antigen scheme (94). These antigens were compared to the 
infecting serotypes using the bacterial agglutination test. 
Endotoxin Evaluation of Vaccines 
The H antigen, formalin-killed vaccines were tested for endotoxin 
using the Limulus Amoebocyte Lysate test (LAL) (M. A. Bioproducts, 
Walkersville, Maryland) according to the manufacturers directions. 
Known concentrations of ~ coli endotoxin were compared to dilutions 
of the sample to be tested. Three concentrations of the serotype 
braenderup and agona vaccine were tested; the McFarland three concen-
tration, a 1:2 dilution and a 1:4 dilution. 
Bacterial Agglutination Test 
Antibody was titrated by the microtiter method. Roundbottomed, 
96 well microtiter plates (Titertek Microliter Plates, Flow Labs, 
Rockville, Maryland) were used (95). 
Two-fold serial dilutions of an initial 1:10 dilution of serum 
were made in PBS so that each well contained 100 microliters. An equal 
volume of antigen was added to each well. One well containing only 
antigen and PBS was used as a control. The plates"were covered and 
incubated at 37 C overnight and read the next morning using reflected 
light. The titer was the reciprocal of the last well in which 
agglutination was observed (95). 
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Skin Tests 
Horses were prepared for skin testing by shaving the neck with an 
electric clipper and then cleaning the skin with 70 percent alcohol 
which was allowed to air dry. The antigen was injected in 0.1 ml 
volumes intradermally with a tuberculin syringe and a 26 gauge, 3/8 
inch needle (Becton Dickinson and Company, Rutherford, New Jersey) on 
the lateral aspect of the neck between the angle of the jaw and the 
shoulder (82, 83, 84, 85, 89). The day that skin testing was performed 
was designated as day one for all experiments. The injection sites on 
horses A and B were checked at 2, 4, 24, 48 and 72 hours and at 24, 48, 
and 72 hours in horses C, D, and E. Horse A was tested with serotype 
braenderup antigen and horses B, C, D, and E were tested with serotype 
agona antigen. A PBS control was omitted in horse A, but used for 
testing the other horses. 
Pathology 
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Horses A an& B were euthanized on day 111 and on day 115 of the 
experiments, respectively, and postmortem examinations and fecal cultures 
were performed. In addition, liver,. spleen, kidney and the area of skin 
which received the undiluted antigen were collected from horse B and 
submitted for histological examination. 
Immunization Schedule 
A week was allowed between skin testing and the first vaccination. 
Initially, the horses were injected subcutaneously to observe potential 
vaccination reactions. Later, injections of gradually increasing 
volumes of vaccine were given intramuscularly. Horses A and B were 
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vaccinated biweekly for six consecutive weeks with serotype braenderup 
and agona respectively. Horses C, D, and E were vaccinated with serotype 
agona. The second of the biweekly vaccinations for these horses was 
given by the ranch manager. If any animal showed a marked reaction to 
the injection, a second injection was not given that week. 
Blood Collection 
Following preparation of the skin with 70 percent alcohol, 10 mls 
of blood were collected from the jugular vein into clot tubes 
(Vacutainer, Becton Dickinson, Rutherford, New Jersey). The blood was 
allowed to clot at room temperature, centrifuged at low speed for five 
minutes and the serum removed and stored at 0 C until used. Blood for 
the collection of white cells was drawn into 10 ml preservative free 
sodium heparin tubes (Vacutainer) and transported to the lab where it 
was maintained at room temperature with mechanical rocking. Cell 
harvesting was begun within three hours after collection. On hot days, 
tubes were transported in a styrofoam cooler with cold but not frozen 
ice packs. This was to protect the blood during transport without 
altering metabolism and microtubule formation (96). 
White Blood Cell Harvest 
Two different techniques for harvesting white blood cells were 
evaluated. The first was an osmotic lysis of the red blood cells 
(RBC's), originally developed for bovine blood (97, 98). This method 
resulted in harvests of lymphocytes, granulocytes, monocytes and 
residual RBC's and was used only in experiment II. Eighty mls of 
sterile distilled water at room temperature was added to 40 ml of 
heparinized blood in a sterile plastic graduated cylinder (Corning, 
Corning, New York) and mixed by inversion of the capped cylinder. 
Exposure to the hypotonic solution was lengthened from an initial time 
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of 30 seconds to 60 seconds because too many RBC's remained. Isotonicity 
was restored by adding 40 ml of sterile, phosphate-buffered (0.013 M) 
double-strength NaCl (1.7 percent solution) at a pH of 6.8. Gentle 
inversion was used to mix the suspension, which was then transferred 
to sterile centrifuge tubes (Corning) and centrifuged at 220 g for 
eight minutes. The supernatant was removed by vacuum aspiration and 
the cells were resuspended in Eagle's Minimum Essential Medium, (EMEM) 
(Gibco). Sodium heparin (Gibco), was added to give a concentration of 
five units per ml. A vortex mixer at a low setting was used to gently 
disperse the pellet of white blood cells in the tissue culture media. 
The suspension was again centrifuged at 220 g for six minutes, the 
supernatant was aspirated and discarded and the cells were resuspended 
in EMEM that contained 50 micrograms per ml of gentamicin reagent 
solution and 10 percent sterile, fetal bovine serum (FBS). The cells 
were washed twice using the above procedure. In some experiments 
10 percent donor horse serum (Gibco) was used instead of FBS. 
The second technique involved cell separation on a concentration 
gradient of Ficoll-Paque (Pharmacia Fine Chemicals, Piscataway, New 
Jersey) which has been adapted for horses (99). Thirty mls of 
heparinized blood were diluted with an equal volume of sterile PBS. 
Between 10 and 12 ml of the diluted blood was carefully layered on 
10 ml of Ficoll-Paque. The tubes were centrifuged at 1800 g for 20 
minutes at room temperature. The layer of mononuclear cells, present 
at the plasma RBC interface, was removed with a sterile pipette. The 
cells, approximately five ml in volume, were washed twice using 20 ml 
of PBS and centrifuged at 1800 g for 10 minutes at room temperature. 
After the second wash the pellet was suspended in three ml of RPMI-1640 
with 100 micrograms of gentamicin sulfate and 20 percent donor horse 
serum. 
Viability Measurement 
The trypan blue dye exclusion test was used to evaluate cell 
viability (98). A drop of cell suspension was mixed with a drop of 
trypan blue, 0.4 percent concentration (Gibco) on a glass slide. 
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One hundred cells were counted and the percent viability was determined. 
Standardization of the Cell Suspension 
The number of mononuclear cells per ml in the tissue culture 
media-cell suspension was determined using the Unopette Test (Becton 
Dickinson). Cells were counted in a Neubauer improved hemocytometer. 
The total number of white blood cells was determined by counting the 
four large corner squares of both chambers, dividing by two and 
multiplying by 50,000 to give cells/ml. The concentrated cell 
suspension was then diluted with RPMI-1640, which contained gentamicin 
sulfate and donor horse serum, to give a final concetration of 100,000 
cells/100 microliters (97). 
Leukocyte Migration Inhibition Test 
The procedure of Dorsey, developed for studying Brucella abortus 
in cattle, was used for the leukocyte migration inhibition (LMI) test 
(97). Agarose (Oxoid, London, England and Seakem, SMC Corporation, 
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Rockville, Maryland) two percent in distilled water was steamed for 20 
minutes then held in a rocking water bath at 48 C until used. Double 
strength Eagle's Minimum Essential Medium (2x EMEM) was prepared. The 
2x EMEM was filter-sterilized (Nalgene, Nalge Co., Sybron Corp., 
Rochester, New York) and gentamicin sulfate (final concentration 20 
percent) were added to the solution which was then equilibrated at 48 C. 
The agarose and EMEM solutions were mixed together under a laminar 
flow hood. Plates were prepared by pouring 7 ml of the agarose-tissue 
culture medium into sterile 60 mm by 15 mm tissue culture plates. 
When the plates solidified six wells were cut, each measuring 4 mm in 
diameter and 10 mm apart by use of a template. A sterile Pasteur 
pipette and vacuum system were used to aspirate the agarose from the 
wells. 
Cells collected by the flash lysis technique were not counted in 
Dorsey's technique, because they clumped, but were mixed well and 
divided into two equal volumes in separate tubes before the third wash. 
The cells in each tube were then resuspended in 50 microliters of EMEM 
containing 10 percent FBS and 50 micrograms/ml of gentamicin sulfate. 
One tube served as the control and the second received 50 microliters 
of antigen. The cell suspensions were incubated in a shaking water 
bath at 37 C for 90 minutes, vortexed gently to resuspend the cells 
at the end of the incubation period, and then used to fill the wells 
of the agarose plates. The plates were then incubated at 37 C for 
24 hours in an incubator with 95 percent air saturated with water 
vapor and five percent co2• Following incubation, the plates were 
flooded with 10 percent formalin for 20 minutes, the agar was removed, 
and the cells were stained with Wright-Giemsa stain (Volu-Sol, 
Medicare Industries Inc., Las Vegas, Nevada). The plates were then 
rinsed with distilled water and air dryed. The diameters of the 
migration zones were measured using an ocular micrometer (American 
Optical, Buffalo, New York). In some of the tests donor horses serum 
was substituted for the FBS in the medium and cells were collected by 
density centrifugation. 
Lymphocyte Stimulation Test 
Lymphocytes were harvested by differential centrifugation on 
Ficoll-Paque as previously described for mononuclear cell collection. 
The cells were standardized and a concentration of 100,000 cells per 
100 microliters per well was used for the lymphocyte stimulation test. 
One hundred microliter aliquots of the cell suspension were placed in 
a 96 well tissue culture plate (Costar, Cambridge, Massachusetts) using 
an automatic pipette (Finnpipette, Lab Systems, Helsinki, Finland). 
Antigens 1 through 10, prepared as described before, were added in 
100 microliter amounts. Controls consisted of 100 microliters of 
tissue culture media with antibiotic and horse serum. All antigens, 
mitogens and the controls were run in triplicate except as noted in 
the results. 
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The following mitogens were reconstituted according to manufacturers 
recommendations and used in the LST test: Bacto Phytohemmaglutinin, PHA 
(Difco), Bacto Concanavalin A, ConA (Difco), and Pokeweed mitogen PWM 
(Gibco). The Con A was made up to five mg;ml and the PW}f four mg/ml; 
the activity for the PHA was unknown by the manufacturer but rehydrated 
according to directions. The mitogens were diluted 1:5, 1:10, and 1:20 
in RPMI-1640 for use in the test. These dilutions were designated 
respectively as 1, 2, and 3. The covers were then taped on and the 
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plates were incubated at 37 C in a five percent co2 incubator with 
95 percent air and water vapor for 72 hours. At the end of this time 
20 microliters of tritiated thymidine, prepared by the addition of five 
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ml of methyl- H thymidine, five microcuries per millimole (ICN, Irvine, 
California) to 120 ml of RPMI-1640 containing 50 micrograms/ml of 
gentamicin sulfate was added to each well. After an additional incuba-
tion period of 18 hours the cells were killed by putting the plates into 
the freezer compartment of a standard, frost-free refrigerator until 
frozen. The plates were thawed and the cells were harvested onto glass 
filter paper discs using a cell harvester (Titertek Cell Harvester, 
Flowlab, McLean, Virginia). 
The paper was allowed to dry at room temperature for several hours, 
then the discs were placed in two mls of scintillation fluid [Bis-MSB 
(two percent) and PPO (98 percent) premixed scintillation powder, ICN] 
and read in a scintillation counter (Packard Tri-Carb 300, Packard 
Instrument Co., Downersgrove, Illinois). The level of 3 H-thymidine 
uptake was measured and the stimulation index was calculated (94, 98). 
Data Analysis 
A computer program was written so that the scintillation counts 
could be entered on the main frame computer at the university. The 
only statistic performed was the determination of the means of the 
counts per minute. The stimulation index was calculated by the 
standard procedure (96, 100). 
CHAPTER IV 
RESULTS 
Salmonella enteritidis serotype braenderup was isolated twice from 
horse A during experiment I in fecal samples on days 22 and 59. However, 
the organism was not recovered from the mesenteric lymph nodes and the 
distal small intestine when horse A was euthanized on day 111. In 
experiment II, serotype agona was isolated from mesenteric lymph nodes 
as well as from the distal small intestines of horse B at necropsy; 
however, two fecal samples collected during the experiment were 
culturally negative. Although serotype agona was also isolated from 
horses C, D, and E prior to beginning the experiment, fecal samples 
collected twice during experiment III were culturally negative. Fecal 
samples were collected each day for five days from control horses F and 
G before they were used in this study. Culturing by the previously 
described methods resulted in no isolation of salmonella. 
The H antigen preparations of serotype agona and braenderup were 
used as vaccines. Endotoxin was evaluated in these preparations using 
the LAL test. The McFarland three concentrations and a 1:2 PBS 
dilution of both serotypes showed a positive reaction to the LAL test 
indicating endotoxin at the level of 0.25 ng/ml. The 1:4 dilution of 
the vaccines were negative. 
Serotype braenderup was used to skin test horse A and serotype 
agona was used to skin test horses B, C, D, and E. The purpose of the 
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skin test was two-fold. Sensitivity to the antigen was determined and 
the appropriate concentration of vaccine to use was decided from the 
results of this test. In addition the delayed-type hypersensitivity 
response to the salmonella antigen was evaluated by the presence of a 
reaction 72 hours after injection (79). The prevaccination skin test 
results for horse A were: a reaction to the undiluted and a 1:4 dilution 
of the skin test antigen. Post-vaccination results were similar except 
that there was also a reaction to the 1:16 dilution of antigen (Table I). 
Horse B had a prevaccination reaction to the undiluted, and a minimal 
reaction to the 1:20 dilution. A slight swelling was noted at all 
injection sites at four hours. The undiluted and 1:20 antigen dilutions 
resulted in firm, 2 em, circumscribed reactions that were gone within an 
additional four days. The postvaccination reaction to the undiluted 
antigen resulted in frank necrosis at the injection site and swelling 
of the entire ipsilateral side of the neck. Seventy-two hours after 
the injections were given all the antigen skin test reactions were less 
than 2 em in diameter except for the undiluted site which was larger 
and contained a necrotic center with a scant amount of thick, yellow-
whiteexudate (Table II). 
Undiluted antigen was not used to test horses C, D, and E because 
of the reaction of horse B and only prevaccination skin tests were 
performed. Twelve hours after injection, horses C, D, and E had 
reactions at the 1:20, 1:40, and 1:80 dilutions. After 72 hours, 
horses C and D had reactions to the 1:20 dilution (Table III). Turbidity 
was noted at 72 hours in the fluid thioglycolate tube used to test the 
skin test antigens of horses C, D, and E. The antigen was diluted and 
used when the 48 hour sterility test showed no growth. Inadvertently, a 
TABLE I. Skin test results for horse A. 
Dilution** 
Undiluted 
1:4 
1:16 
1:64 
1:256 
1:1024 
* 
Day 3 
Reactions* 
Skin test performed on day 0 and evaluated 72 hours later. 
** Serotype braenderup antigen in PBS dilutions. 
++2 em circumscribed swelling. 
No re.action. 
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Day 11 
++ 
++ 
++ 
TABLE II. Skin test results for horse B. 
Reactions* 
Dilution** Day 3 
Saline Control 
Undiluted ++ 
1:20 + 
1:40 
1:60 
* . Skin test performed on day 0 and evaluated 72 hours later. 
** Serotype agona antigen in PBS dilutions. 
+Less than 2 em, circumscribed swelling. 
++2 em, circumscribed swelling. 
++++4 em, frank necrosis. 
No reaction. 
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Day 115 
++++ 
+ 
+ 
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TABLE III. Skin test results for horses C, D, and E. 
Reactions* 
Dilution** Horse C Horse D Horse E 
Saline Control 
1:20 + + +I-
1:40 
1:80 
* Skin test performed on day 0 and evaluated 72 hours later on 
day 3. 
** Serotype agona antigen in PBS dilutions. 
+Less than 2 em, circumscribed swelling. 
+/-Palpable but not measurable swelling. 
No reaction. 
culture that was not killed was used to skin test the horses in 
experiment III. With the exception of horse D, which developed a 
transient diarrhea, there were no clinical signs and all the horses 
were bright, alert and did not go off feed. 
The McFarland three dilution of the formalin-killed preparation 
which preserved the H antigens was used as the vaccine. This standard 
was approximately equal to a dilution of 1:80 on the skin test and was 
used because no horse demonstrated an initial skin reaction to this 
dose after 72 hours. The infected horses were vaccinated biweekly for 
a period of up to seven weeks. The vaccination schedules are given in 
Tables IV-VI. Horse B was not vaccinated on day 100 of experiment II, 
when she was found down in her stall, unable to rise (Table V). Horses 
C, D, and E had vaccination reactions to the dose given on the 15th 
day of experiment III. All demonstrated marked swelling of the neck 
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in the region of the vaccination site. The animals were rested for one 
week and a reduced volume of vaccine was given (Table VI). In addition, 
the stools of horse D were loose for several days immediately following 
vaccination throughout the experiment. On day 36, horse E developed 
swollen hocks after the injection was given. However, the animal was 
never lame and showed no other clinical signs while the swelling 
gradually decreased. 
The results of the bacterial agglutination tests in experiments I, 
II, and III were as follows: horse A had titers to 0 and H antigen 
preparations of serotypes braenderup, heidelberg, newport and anatum. 
The H antigen titers were consistently higher than the 0 antigen titers 
and the highest titers were to the H antigen preparation of the 
infecting serotype, braenderup (Table VII). 
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TABLE IV. Vaccination schedule for horse A. 
Day of Experiment* Volume 
4 0.5 ml** 
8 1.0 ml** 
11 1.0 ml 
15 1.5 ml 
18 2.0 ml 
22 2.0 ml 
28 3.5 ml 
31 4.0 ml 
35 4.0 ml 
38 2.0 ml 
42 5.0 ml+ 
44 5.5 ml+ 
49 5.5 ml+ 
52 6.0 ml+ 
* Serotype braenderup used as antigen. 
** Injections given subcutaneously, all others 
given intramuscularly using different muscle masses. 
+ Volumes greater than 4.0 ml were divided and 
given into two sites. 
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TABLE V. Vaccination schedule for horse B. 
Day of Experiment* Volume 
65 1.0 ml** 
69 1.5 ml** 
72 2.0 ml 
76 2.0 ml 
79 3.0 ml 
84 4.0 ml+ 
87 4.0 ml+ 
94 5.0 ml+ 
98 5.5 ml+ 
101 6.0 ml+ 
105 6.0 ml+ 
* Serotype agona used as antigen. 
** Injections given subcutaneously, all others 
given intramuscularly using different muscles masses. 
+ Volumes greater than 4.0 ml were divided and 
given into two sites. 
TABLE VI. Vaccination schedule for horses C, D, 
and E. 
Day of Experiment* Volume 
8 0.5 ml** 
12 1.0 ml** 
15 1.5 ml** 
21 1.0 ml** 
29 1.0 ml 
33 1.5 ml 
36 2.0 ml 
50 2.0 ml 
54 2.0 ml 
* Serotype agona used as antigen. 
** Injections given intramuscularly using 
different muscle masses. 
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TABLE VII. Salmonella agglutination titers for horse A. 
Days Post Vaccination* 
Serotypes Group** 0 55 
braenderup+ c1 
H antigen 20,480 327,680 
0 antigen 2,560 20,480 
heidelberg B1 
H antigen 80 640 
0 antigen 20 320 
newport c 
H antigen 40 160 
0 antigen 10 20 
ana tum E 
H antigen 2,560 20,480 
0 antigen 40 320 
* Two fold serial dilutions of a 1:10 serum dilution using a 96 well 
microtiter plate. 
** Ewing's abbreviated antigen scheme (94). 
+ Serotype infecting horse A. 
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Titers to all serotypes increased after vaccination; however, the 
most significant increase was to braenderup. Horses B, C, D, and E, 
infected with serotype agona, all had prevaccination titers to serotypes 
agona, newport, heidelberg, and anatum. The titers increased to all 
serotypes during vaccination; but, the highest titers were still to the 
H antigen preparation of the infecting serotype (Tables VIII-IX). 
Horses F and G, the controls, had titers to serotypes agona, heidelberg, 
anatum and newport, with the highest titers to the H antigen preparations. 
Horse F had the highest titer to serotype anatum and horse G had the 
highest titers to serotypes agona and anatum (Tables X-XI). 
White blood cells harvested by the flash lysis technique were not 
counted because problems with clumping prevented an accurate count. 
White blood cells collected by differential centrifugation on Ficoll-
paque, belonged to the mononuclear series and were counted. Their 
numbers varied from week to week and from animal to animal. Horse B 
had a range of 15,800 to 17,600 cells/ml after differential centrifu-
gation and resuspension in tissue culture media. Horse C ranged from 
33,200 to 34,800 cells/ml; horse D, 25,600 to 55,800 cells/ml; and 
horse E, 22,500 to 38,600 cells/ml. The control horses also demonstrated 
similar variability with horse F having between 18,700 and 20,600 
cells/ml and horse G having between 13,000 and 42,000 cells/ml. 
Cell viability, measured by trypan blue dye exclusion was far 
more consistent and ranged between 95 and 100%. The average viability 
was 98% for all samples tested. 
Results of the leukocyte migration inhibition test were variable. 
Migration was observed on only one occasion. Despite the substitution 
of Donor Horse Serum for FBS and Sea Kern Agarose for Oxoid agarose, as 
TABLE VIII. Salmonella agglutination titers for horse B. 
Days Post-Vaccination* 
Serotypes 1 8 15 22 29 36 43 50 
heidelberg 
H antigen 80 80 100 160 320 640 320 640 
0 antigen 40 80 80 80 80 160 80 160 
agona** 
H antigen 2,560 20,480 20,480 40,960 81,920 81,920 163,840 327,680 
0 antigen 20 40 80 80 160 320 320 640 
newport 
H antigen 40 40 40 80 80 80 80 160 
0 antigen 20 20 20 40 40 40 40 80 
ana tum 
H antigen 160 320 320 320 320 320 320 640 
0 antigen 40 160 160 160 160 160 160 160 
--
* Two-fold serial dilutions of a 1:10 serum dilution using a 96 well microtiter plate. 
** Serotype infecting horse B. 
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640 
160 
327,680 
640 
320 
80 
640 
160 
.p. 
.p. 
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TABLE IX. Salmonella agglutination titers for horses C, D, and E. 
Serotypes* 
heidelberg agona** newport ana tum 
Day of Antigens 
Experiment Horse H 0 H 0 H 0 H 0 
1 c 80 40 1,280 80 320 40 1,280 40 
D 80 40 640 40 640 40 320 40 
E 40 20 10,240 80 80 40 320 80 
8 c 160 80 10,240 80 640 40 1,280 80 
D 160 80 1,280 80 320 40 640 80 
E 80 40 40,960 80 320 80 640 80 
15 c 160 40 10,240 80 640 40 2,560 80 
D 80 40 2,560 80 320 40 640 80 
E 80 40 81,920 160 640 80 640 80 
22 c 320 80 10,240 80 1,280 80 2,560 80 
D 160 80 10,240 160 320 80 320 80 
E 80 40 40,960 80 320 80 640 80 
36 c 320 80 20,480 80 640 80 1,280 80 
D 160 40 10,240 160 640 160 640 80 
E 80 40 81,920 160 640 80 640 80 
43 c 320 80 20,480 80 1,280 80 1,280 80 
D 160 80 10,240 160 640 160 640 80 
E 80 40 163,840 160 640 80 640 80 
* Two-fold serial dilutions of a 1:10 serum sample in a 96 well 
microtiter plate. 
** Serotype infecting horses C, D, and E. 
TABLE X. Salmonella agglutination titers for control horses F and G, 
experiment I. 
Serotypes* 
heidelberg agona newport ana tum 
Day of Antigens 
Experiment Horse H 0 H 0 H 0 H 0 
1 F 40 20 160 40 80 40 320 80 
G 40 10 160 40 80 40 160 40 
8 F 40 20 160 80 80 40 320 80 
G 40 20 160 40 80 40 160 40 
15 F 20 10 160 40 160 40 320 40 
G 40 20 160 80 80 40 160 40 
22 F 40 20 160 80 80 40 320 40 
G 40 20 160 40 80 20 160 40 
36 F 40 10 160 40 80 40 320 80 
G 40 20 160 80 80 40 160 80 
43 F 40 20 160 80 80 40 320 80 
G 40 20 160 40 80 20 160 40 
* Two-fold serial dilutions of a 1:10 serum dilution in a 96 well 
microtiter plate. 
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TABLE XI. Salmonella agglutination titers for control horses F and G, 
experiment II. 
SerotyEes* 
Day of heidelberg agona newport ana tum 
Experiment Horse H 0 H 0 H 0 H 
47 
0 
1 F 40 20 320 80 160 40 640 160 
G 40 20 320 80 160 40 160 40 
36 F 20 10 160 80 160 40 320 80 
G 40 20 320 80 160 40 80 40 
43 F 40 20 320 40 80 40 320 80 
G 40 20 640 80 160 40 160 40 
50 F 40 20 160 40 80 40 320 80 
G 40 20 320 80 160 40 160 40 
57 F 40 20 160 80 80 40 160 80 
G 40 20 320 80 160 40 80 40 
* Two-fold serial dilutions of a 1:10 serum dilution in 96 well 
microtiter plate. 
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well as a change to cell collection by density gradient centrifugation, 
the test did not produce positive results and was abandoned. The 
lymphocyte stimulation test (LST) was used instead to evaluate CMI. The 
level of three H-thymidine uptake was measured in a liquid scintillation 
counter and the stimulation index was calculated (96, 100). 
The mitogen dilutions which gave the highest SI results for control 
horse G were: PWM dilution two on day one (3.93) and PHA dilution two 
on day one (6.01), of experiment III. 
Results of the LST test were variable; however #6 dilution of 
serotype agona antigen prodHced the most significant SI compared to 
other dilutions (Tables XII and XIII). When SI and days after vaccina-
tion were graphed for antigen #6, test horse B did not have significantly 
greater SI than the control horses F and Gin experiment I (Figure 1). 
However, in experiment II the mean SI for the three test horses, C, D, 
and E, was greater than the mean of the SI for the two control horses, 
F and G (Figure 2). 
At the end of experiment I, horse A was euthanized and a gross 
postmortem examination was performed. The horse had gained several 
hundred pounds during the experiment and no significant postmortem 
changes were noted. Tissues were not examined histologically. Animal B 
was euthanized on the 115th day of the second experiment. Ascarids were 
noted at postmortem examination but no remarkable gross changes were 
noted. Histopathology of the kidney revealed aggregates of lymphocytes, 
plasma cells and macrophages in the interstitial cortical area (Figure 
3). Tufts of some glomeruli were adherent to Bowman's capsule and 
there was a variation in size between glomeruli. There was only a 
scant amount of material in the tubules and damage to the kidney was 
TABLE XII. Lymphocyte blast transformation data*, serotype agona 
antigen #6--experiment I. 
Days After Initial Vaccination 
Animals 8 15 22 29 36 43 
B 1.69 + 1.21 1.25 
2.70 NA** 1.77 
NA NA NA 2.50 2.53 
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1.16 
* SI mean of counts per minute for triplicate stimulation culture 
mean of counts per minute for triplicate control cultures · 
+SI less than one. 
++ Control horse. 
** Not available. 
TABLE XIII. Lymphocyte blast transformation data*, serotype agona 
antigen #6--experiment II. 
Days After Initial Vaccinati0n 
Animals 8 15 22 36 
c 4.27 + 
D 6.31 
1.18 25.27 
2.59 
so 
43 
1.13 
1.98 
4.07 
* SI = mean of counts per minute of triplicate stimulated cultures 
mean of the counts per minute of triplicated control cultures· 
+SI less than one. 
++Control horse. 
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Figure 1. Experiment II: Comparison of Antigen Six Stimulation Indices (SI) of 
Test Horse B (Solid Line) with the Mean of Control Horses F and G 
(Dashes). Significant SI are Greater than Two. 
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Figure 2. Experiment III: Comparison of Antigen Six Stimulation 
Indices (SI) of the Mean of Test Horses C, D, and E 
(Solid Line) with the Mean of Control Horses F and 
G (Dashes). Significant SI are Greater than Two. 
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Figure 3. Kidney. Horse B. Mild Glomerular Damage. 
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probably subclinical. In the spleen, the white pulp was not well formed 
and there was secondary follicle development which would be consistent 
with a B cell proliferation and a depletion of T cells. The red pulp 
was hypercellular and there was a significant amount of hemosiderin 
deposited in the tissue (Figure 4). Small neutrophilic foci associated 
with necrotic hepatocytes were scattered throughout the liver (Figure 5). 
These lesions have been called typhoid nodules and are commonly 
associated with salmonellosis (99). Some of the lesions were chronic, 
but many consisted solely of PMN's indicating an acute infection. In 
addition to kidney, spleen and liver, the postvaccination undiluted 
antigen skin test site was also histologically evaluated to determine 
if the reaction was an arthus reaction or delayed-type hypersensitivity. 
The degree and extent of necrosis of the tissue was greatest around 
the vessels (Figure 6). The reaction was a combination of inflammation 
and ischemic necrosis but the cause could not be determined by 
histopathology. 
Figure 4. Spleen. Horse B. Secondary Follicle 
Development and Hemosiderin 
Deposition. 
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• Figure 5 . Liver. Horse B. Necrotic Hepatocytes 
Surrounded by Polymorphonuclear 
Leucocytes . 
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Figure 6. Skin. Test Site. Horse B. Diffuse 
Inflammatory Infiltrate in the 
Dermis. 
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CHAPTER V 
DISCUSSION 
Salmonella was not isolated from the mesenteric lymph nodes and 
small intestine of horse A at postmortem, although serotype bFaenderup 
was isolated twice from fecal samples during experiment I. There are 
several explanations for this. One is that the animal was still shedding 
the organism but in numbers too low to recover culturally. Another is 
that the horse was no longer infected. The latter is consistent with 
the clinical signs for this animal; horse A gained weight and developed 
firmer stools during the experiment. 
Serotype agona was cultured from the mesenteric lymph nodes and 
small intestine of horse B at necropsy but not from two fecal samples 
taken during experiment II. Salmonella is known to infect and persist 
in the regional lymph nodes of carrier horses even though fecal culture 
is negative. Horse B was the most cachectic animal in the study and 
the isolation of salmonella from this animal was consistent with the 
clinical appearance of this horse. 
The first isolation of serotype agona from horses C, D, and E was 
made when they were less than six months old, a very susceptible age 
group. These animals were seen only once a week and feces were collected 
from the corrals where the horses were individually housed. Although 
horses C, D, and E had been culturally identified as shedders of 
serotype agona, the organism was never recovered from fecal samples 
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during experiment III. It is possible that these animals were still 
infected and shedding the bacteria in low numbers or carrying the 
bacteria in the regional lymph nodes. Such inconsistencies in isolation 
have been noted in the literature. A positive culture can follow a 
series of negative ones (8). Another possibility is that horses C, D, 
and E were no longer carriers of serotype agona but had cleared the 
infection. This is consistent with the clinical appearance of these 
animals. They gained weight and their stool consistency improved after 
hyperimmunization. 
Although there are many modifications of the fecal enrichment 
techniques for salmonella isolation described in equine literature, 
the rate for successful culture is poor. The most consistent isolation 
of the organism in this study was from horse A where a slightly different 
cultural technique was used. (Ten grams of feces in 10 ml of PBS were 
macerated in a Stomaker then used to inoculate selenite and tetra-
thionate broths which were later used to streak Salmonella-Shigella 
and brilliant green agar plates.) This technique was used by the 
Microbiology Laboratory at the College of Veterinary Medicine at 
Washington State University and gave better results compared to other 
isolation techniques. A different technique was used in experiments II 
and III and the cultural results were more variable. Although there 
was a difference in serotypes between experiments I, II, and III, the 
cultural technique used in experiment I may have been superior and 
variability in fecal isolations in later experiments could be due to 
technique. 
All infected horses were skin-tested with undiluted and diluted 
formalin-killed antigen. The skin test was used to evaluate the cell 
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mediated immune response (CMI) to antigen. The pre and postvaccination 
skin test reactions were similar in horse A. The only difference was a 
postvaccination response to a more dilute concentration of serotype 
braenderup. A saline control was omitted during skin testing of horse A; 
however, the omission was not critical to the test since the animal did 
have some negative reactions to several dilutions. If all the skin test 
sites had been positive the control would have differentiated reactions 
due to technique versus reactions to the organism. 
The postvaccinational skin test responses of horse B were different 
from horse A. Horse B had a response to a more dilute antigen and 
frank necrosis occurred at the site where the undiluted antigen was 
injected. No definite conclusions could be drawn from histology of the 
lesion, but the necrosis was worse around the vessels as if they were 
the primary sites of the reaction. Biopsy of all the skin test sites 
in horse B would have been valuable because the severity of the reaction 
to the undiluted antigen made it impossible to determine if a delayed-
type hypersensitivity reaction occurred. 
The concentrated antigen in experiment III contained live organisms 
and was inadvertently used to skin test horses C, D, and E. The animals 
had swellings at all injection sites within four hours but these were 
gone at 12 hours except for the 1:20 dilution. The animals had no 
adverse clinical signs and the skin test reactions never appeared 
infected. However, even with the low numbers of organisms present 
(0.1 ml of 1:20, 1:40, and 1:80 dilution), use of a live culture may 
have had a number of effects on these horses. First, the animals were 
exposed to different antigens, flagellar and cell-wall-associated that 
are usually changed by formalin or heat-killing. Also, the best 
vaccines against intracellular parasites are known to be modified live 
ones (74, 75). Although there were no clinical signs consistent with 
bacterial multiplication, it is possible that the skin test may have 
effected the immune response and changed the results of experiment III. 
The prevaccination skin test reactions were similar between horses 
B, C, D, and E. These animals were infected with serotype agona and 
were from the same ranch. Horse A did not exhibit as marked a response 
as horse B to the concentrated antigen dilution. Horse A was infected 
with serotype braenderup. These results may indicate that different 
serotypes produce different degrees of response when compared by skin 
testing. Another possibility for the reduced response of horse A is 
that the animal was immunosuppressed. This is known to occur in man 
and animals with chronic infections such as salmonellosis and occurs 
in horses with chronic diarrhea (83). 
Intradermal injection of PHA has been used to evaluate 
T-cell responses and could have been given concomitantly with other 
antigen dilutions to estimate CMI. The state of the immune status of 
infected horses should be known before the animals are used in vaccine 
studies (102). Even though carriers probably have a reduced immune 
response, comparison of prevaccination response is low. The comparison 
may indicate that a response did occur although low compared to normal. 
Or if there was no CMI demonstrated after vaccination it could be 
because the animal was too immunosuppressed to respond to any 
stimulation. The carrier state for salmonellosis is not well 
understood in man or animals and baseline data may provide insights. 
The vaccination schedule used has not been described in the 
literature for salmonella bacterins in horses. In general, the series 
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was tolerated by all the horses. However, as the volumes increased 
and were given into two sites, the animals exhibited some discomfort 
and became more difficult to handle. Horses A and B demonstrated no 
reaction to any of the injections. Horses C, D, and E had a marked 
swelling at the vaccination site given on day 15 of experiment III. 
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One week later a reduced volume was given with no reactions and biweekly 
injections were resumed. Since high concentrations of agglutinating 
antibodies can cause such reactions, titers were determined. Titers 
had increased three-fold from day one to day 15 in horses D and E, 
and four-fold in horse C to the H antigen preparation of serotype agona. 
Two-fold increases occurred to the 0 antigen preparation for horses D 
and E, while no increase was noted for horse C. Horse E had a two-fold 
increase in titer between days one and eight, but no reactions had 
occurred when the animal was vaccinated on day eight. Also, the day 
one titer of this horse was greater than that on day 15 for horse C 
and equal to that of horse D, yet no initial reaction to the first 
injection occurred in horse E. Therefore, the antibody concentration 
did not appear related to the reaction. Another explanation for the 
reaction is that there was a problem with vaccination technique. This 
is consistent with the absence of vaccinal reactions when hyper-
immunization was resumed. 
In general, equine clinicians do not use titers when evaluating 
potential cases of salmonellosis because titers are not commonly 
performed and there is cross reaction between members of the 
Enterobacteriaceae. However, there are many tests where cross reactions 
or high background titers occur. These problems are minimized by 
ignoring low titers and considering large increases (four-fold) as 
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significant in paired sera. This study demonstrated that although all 
equine sera had titers, infected horses had much higher antibody levels 
to the H antigen preparations of the serotype which caused the infection. 
This finding has clinical as well as epidemiological significance and 
should be evaluated in greater detail in other infected horses. 
Since CMI is considered to be responsible for protection and cure 
of infections caused by salmonellosis, a test was needed to evaluate 
the responses produced by hyperimmunization with an autogenous bacterin. 
The LIF procedure developed by Dorsey was tested once during a preliminary 
experiment and appeared to work (95). However, there was never migration 
of the control white blood cells during experiment II. Changes in 
agarose, serum and white blood cell collection techniques did not help. 
The cells were viable by the trypan blue dye exclusion test; however, 
this test measures the integrity of the cell membrane not the ability 
of the cell to produce a product, divide or to move. This test would 
show viability even if the cells could not function in the test system. 
Also, the LIF procedure of Dorsey was developed for use in the bovine. 
Perhaps the system may require additional modifications when equine 
blood is used. The LIF test was abandoned and the LST test was used 
instead. The LST results were also variable, however, some variability 
is common in this test (94). 
The stimulation index (SI) was calculated and used to compare 
antigen and mitogen responses. In general, if the SI is greater than 
2.0 the response is significant (94, 105). Antigen dilution six 
produced higher SI is all horses although on certain test dates there 
was not stimulation (SI less than 1.0). Although there was no 
significant difference in SI between test horse B and control horses 
F and G to antigen six (horse B was in poor physical condition and had 
chronic ongoing visceral salmonellosis), the mean for test horses C, 
D, and E was greater than the mean for control horses F and G when SI 
was plotted against time. This indicated that antigen six produced 
some CMI in these horses. However, the SI produced by the mitogens was 
much less than expected and in some cases less than the SI produced by 
the antigens in control horses. One explanation for this is that 
inappropriate mitogen dilutions were used. No preliminary experiment 
had been done to determine the best concentration in the test system. 
Instead, a number of mitogen concentrations were used at the same time 
in order to speed up the experiment. Another possibility was that the 
cells were damaged or an intoxicant was in the system. However, this 
seems less likely since stimulation did occur in test and control 
horses. 
Cell mediated immunity is difficult to evaluate. Although the 
techniques developed are accurate, they are sensitive to minor 
variations in technique as well as physiological changes in the test 
animal. The LST test exhibits variability between different "normal" 
animals and even for the same animal on different test dates. Such 
variability has caused some investigators to discount the test. 
However, the alternative tests (MIF, LIF and skin testing) also have 
problems with variability. Perhaps these problems will be resolved 
in the future as research on CMI continues. 
Clinically, all horses responded favorably to hyperimmunization. 
Horse A gained weight and developed a firmer stool; horses C, D, and 
E grew normally and developed better stool consistency and haircoat. 
Horse B did not respond as well but had no negative reactions to the 
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vaccination series even though this animal had chronic ongoing visceral 
salmonellosis. Hyperirnrnunization appears to provide clinical improvement 
in horses infected with serotype agona or braenderup and merits more 
research as well as serious consideration when attempting to cure a 
chronically infected carrier. 
CHAPTER VI 
SUMMARY 
Humoral and cell mediated immunity as well as clinical response 
were evaluated in five equine carriers of salmonella after hyper-
immunization using an autogenous formalin-killed bacterin. 
Hyperimmunization consisted of a series of gradually increasing doses 
of the bacterin given biweekly for a period of time (six to seven 
weeks) and represented a novel vaccination scheme for an autogenous 
salmonella bacterin in the horse. The vaccination schedule was well 
tolerated by the horses. However, as the volumes increased requiring 
injection into two sites, the animals exhibited some discomfort and 
became more difficult to handle. 
Sera of control and infected horses were titered using a battery 
of H and 0 salmonella antigens of various serotypes of Salmonella 
enteritidis. These included serotypes: heidelberg, newport, agona 
and anatum which represented groups: C, A, D, and E, respectively. 
In general, titers to the H antigens of all the serotypes increased 
in the vaccinated animals during the experiment. Although all horses 
had titers, even the controls, infected horses had a significantly 
higher antibody response to the H antigen preparation of the infecting 
serotype. Equine clinicians do not use titers when evaluating potential 
cases of salmonellosis because titers are not commonly performed and 
there is cross reaction between members of the Enterobacteriaceae. 
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However, this study demonstrated that infected horses had much higher 
antibody levels to the H antigen preparations of the infecting 
serotype of salmonella. This finding has clinical as well as 
epidemiological significance and should be studied further. 
Cell mediated immunity was evaluated using the lymphocyte stimula-
tion test. Although the results were variable, especially the response 
to the mitogen preparations, significant stimulation was demonstrated 
to Salmonella enteritidis serotype agona antigen concentration six in 
three of four infected horses, compared to controls, after the series 
of vaccinations. 
No significant adverse effects occurred during hyperimmunization. 
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In fact, four of the five vaccinated horses showed definite clinical 
improvement including: weight gain, better stool consistency, normal 
growth and better coats. The horse which showed no improvement was 
found to have a chronic active case of visceral salmonellosis at 
postmortem; yet,this animal had no apparent reactions to the vaccination 
series• 
Hyperimmunization with a killed autogenous bacterin produced 
positive clinical response with only minimal risk and merits further 
study as an aid to treatment of horses with salmonellosis. 
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TABLE XIV. Lymphocyte stimulation data for horse B. 
Stimulation Indices* 
Days After Initial Vaccination 
Test 8 15 22 29 36 43 so 
Ag+ 
1 2.11 
@ 
2 
3 1.02 
4 1.34 1.13 1.46 
5 1.35 1.08 1. 21 1.06 
6 1.69 NA 1. 21 1.25 
7 NA 2.02 NA NA 1.68 1.06 
-e-PWM 
1 1.43 1. 95 1.37 2.10 1. 70 
2 1.82 4.06 4.02 
3 2.48 1.89 1.45 NA 6.09 3.31 
PHA@ 
1 1.33 
2 1.29 1.50 4.11 1. 27 
3 1. 64 2.88 3.87 1.45 
CON-A/ 
1 1.00 4.92 2.63 1.29 
2 1.60 2.13 2.16 
3 1.06 10.58 1. 79 2.47 
* (SI) Stimulation Index = 
x counts per minute for triplicate test cultures 
x counts per minute for triplicate control cultures 
+ Serotype agona antigen. 
-
Pokeweed mitogen. 
@Phytohemagglutinin P. 
I 1' Concanava l.n A 
@ SI less than 1.0. 
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TABLE XV. Lymphocyte stimulation data for control horse F. 
Stimulation Indices* 
Days of Experiment II 
Test 8 15 22 29 36 43 so 
Ag+ 
1 --@ 5.41 1.20 
2 2.47 1.11 
3 2.79 
4 1.24 1.19 
5, 3.44 2.11 
6 2.70 NA 1.77 
7 NA 2.23 NA NA 2.07 
PWM..e-
1 1.02 2. 19 1.60 10.31 3.46 
2 1.09 9.04 3.93 14.71 4.17 
3 2.22 18.43 7.15 NA 11.18 6.88 
PHA@ 
1 2.25 2.74 
2 1.02 3.98 1.45 1.55 11.11 1.81 
3 4.87 2.16 NA 16.57 13.30 2.82 
CON-A/ 
1 2.02 1.29 5.01 6.52 
2 2.34 12.23 1.68 6.19 2.58 
3 1. 97 38.82 4.24 NA 3.41 2.82 
* Stimulation Index (SI) = 
x counts per minute for triplicate test cultures 
x counts per minute for triplicate control cultures 
+ Serotype agona antigen. 
.e- Pokeweed mitogen. 
®Phytohemagglutinin P. 
/Concanavalin A. 
@ SI less than 1. 0. 
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TABLE XVI. Lymphocyte stimulation data for control horse G. 
Stimulation Indices* 
Days of Experiment II 
Test 22 29 36 43 so 
Ag+ 
1 1. 21 
__ @ 
2 2.33 
3 1. 21 1.45 
4 1.22 1. 79 
5 2.42 1. 71 1.30 2.74 
6 2.50 2.53 1.16 
7 2.19 3.76 1.50 2.32 
8 2.09 1.09 
9 5.69 
10 4.64 2.80 
PWM-e-
1 2.42 2.74 1.04 
2 1.22 1.07 5.02 2.12 
3 1. 74 1.33 5.10 3.41 
PHA@ 
1 
2 1. 22 1.18 2.82 2.30 
3 1.29 2.30 
CON-A./ 
1 1.94 2.19 3.14 
2 6.13 1. 45 
3 1.19 
* Stimulation Index (SI) = 
x counts per minute for triplicate test cultures 
x counts per minute for triplicate control cultures 
+ Serotype agona antigen. 
-e-Pokeweed mitogen. 
~Phytohemagglutinin P . 
./Concanavalin A. 
e.SI less than 1.0. 
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TABLE XVIII. Lymphocyte stimulation data for horse C. 
Stimulation Indices* 
Days After Initial Vaccination 
Test 8 15 22 36 43 
Ag+ 
3 
__ G, 
1.14 
4 3.51 1.38 1. 93 
5 1. 53 2.79 1.81 
6 4.27 1.13 
7 2.33 
8 1.54 
9 1. 22 
10 4.85 2.04 
PWM~ 
1 1.07 
2 3.29 1.25 
3 1. 89 1. 59 
PHA@ 
1 2.58 1. 75 1.96 
2 3.12 1.12 1.41 
3 2.15 1.14 
CON-A/ 
1 1. 55 1.23 
2 1.04 1.49 
3 3.04 3.15 
* Stimulation Index (SI) 
x counts per minute for triplicate test cultures 
x counts per minute for triplicate control cultures 
+ Serotype agona antigen. 
-&Pokeweed mitogen. 
~hytohemmagglutinin P. 
1concanavalin A. 
@,SI less than 1.0. 
TABLE XVIII. Lymphocyte stimulation data for horse D. 
Stimulation Indices* 
Days After Initial Vaccination 
Test 8 15 22 36 
3 
4 
5 
6 
7 
8 
9 
10 
PWM-& 
1 
2 
3 
PHl§) 
1 
2 
3 
1. 52 
CON-Al 
1 
2 
3 
* Stimulation Index (SI) = 
1.26 
1.39 
3. 72 
2.80 
6.31 
1.04 
1. 78 
10.10 
4.38 
1. 61 
2.56 
3.23 
2. 72 
2.25 
1.49 
3.02 
x counts per minute for triplicate test cultures 
x counts per minute for triplicate control cultures 
+ Serotype agona antigen. 
-& Pokeweed mitogen. 
~hytohemmagglutinin P. 
1concanavalin A. 
@ SI less than 1.0. 
43 
1.22 
1.15 
2.11 
1. 75 
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TABLE XIX. Lymphocyte stimulation data for horse E. 
Test 
3 
4 
5 
6 
7 
8 
9 
10 
PWM-& 
1 
2 
3 
'PHA@ 
1 
2 
3 
8 
__ @.. 
1.18 
1.17 
1.00 
1.64 
2.63 
2.16 
1.36 
1.50 
1. 25 
Stimulation Indices* 
Days After Initial Vaccination 
15 22 36 
1.27 
8.13 
1.60 
2.91 
1.24 
14.27 
25.96 
2.02 
25.27 
2.02 
6.57 
6.65 
18.84 
8.43 
1.25 
2.53 
1.21 
3.73 
CON-A/ 
1 
2 
3 
* 
1. 59 
2.56 
2.00 
Stimulation Index (SI) = 
x counts per minute for triplicate test cultures 
x counts per minute for triplicate control cultures 
+ Serotype agona antigen. 
~okeweed mitogen. 
~Phytohemmagglutinin P. 
1concanavalin A. 
~ SI less than 1. 0. 
43 
1.94 
1.98 
3.05 
2.23 
4.14 
1. 76 
5.50 
2.05 
1.26 
1.37 
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TABLE XX. Lymphocyte stimulation data for control horse F. 
Test 
3 
4 
5 
6 
7 
8 
9 
10 
8 
--~ 
Stimulation Indices* 
Days of Experiment III 
15 22 36 
2.41 
1.00 
1.65 
1. 70 2.00 1.02 
1.29 2.62 
2.19 
PWM-& 
1 
2 
3 
2.24 
4.75 
4.47 
3.06 
2.31 
10.31 
CON-Al 
1 
2 
3 
2.86 
* Stimulation Index (SI) = 
2.25 
2.57 
2.17 
x counts per minute for triplicate test cultures 
x counts per minute for triplicate control cultures 
+ Serotype agona antigen. 
-E)-
Pokeweed mitogen. 
~Phytohemmagglutinin P. 
1concanavalin A. 
@ SI less than 1. 0. 
43 
1.68 
1.09 
4.07 
4.61 
1.22 
1. 23 
1.86 
2.39 
6.52 
3.90 
4.16 
1. 57 
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TABLE XXI. Lymphocyte stimulation data for control horse G. 
Stimulation Indices* 
Days of Experiment III 
Test 8 15 22 36 
3 
4 
5 
6 
7 
8 
9 
10 
PWM-e.-
1 
2 
3 
PHA® 
1 
2 
3 
CON-Al 
1 
2 
3 
* 
__ @ 
2.03 
1.35 
1.72 
1.38 
2.13 
1.72 
1.28 
Stimulation Index (SI) = 
1. 21 
1.32 
1.15 
4.52 
2.59 
1.21 
1.34 
2.58 
l. 97 
3.12 
x counts per minute for triplicate test cultures 
x counts per minute for triplicate control cultures 
+ Serotype agona antigen. 
-a-Pokeweed mitogen. 
~Phytohemmagglutinin P. 
1concanavalin A. 
@ SI less than 1.0. 
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